Bank Of New York Mellon Corp Collegium Pharmaceutical, Inc Transaction History

Bank Of New York Mellon Corp

$538 Trillion
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 09, 2023	BUY	$23.0 - $29.88 $7.49 Million - $9.73 Million	325,796 New	325,796 $7.82 Billion
Q4 2022 Feb 14, 2023	BUY	$16.14 - $23.55 $5.25 Million - $7.65 Million	324,984 New	324,984 $7.54 Million
Q3 2022 Nov 14, 2022	SELL	$15.46 - $20.1 $33,841 - $43,998	-2,189 Reduced 0.6%	360,454 $5.77 Million
Q2 2022 Aug 15, 2022	SELL	$14.22 - $20.88 $355,627 - $522,187	-25,009 Reduced 6.45%	362,643 $6.43 Million
Q1 2022 May 11, 2022	SELL	$17.2 - $22.5 $187,136 - $244,800	-10,880 Reduced 2.73%	387,652 $7.89 Million
Q4 2021 Feb 11, 2022	BUY	$17.5 - $21.35 $519,837 - $634,201	29,705 Added 8.05%	398,532 $7.45 Million
Q3 2021 Nov 12, 2021	BUY	$17.75 - $25.39 $94,873 - $135,709	5,345 Added 1.47%	368,827 $7.28 Million
Q2 2021 Aug 11, 2021	SELL	$21.74 - $25.28 $611,002 - $710,494	-28,105 Reduced 7.18%	363,482 $8.59 Million
Q1 2021 May 13, 2021	BUY	$19.25 - $26.1 $3.82 Million - $5.18 Million	198,329 Added 102.62%	391,587 $9.28 Million
Q4 2020 Feb 09, 2021	BUY	$17.83 - $22.29 $173,414 - $216,792	9,726 Added 5.3%	193,258 $3.87 Million
Q3 2020 Nov 12, 2020	SELL	$15.78 - $20.82 $72,161 - $95,209	-4,573 Reduced 2.43%	183,532 $3.82 Million
Q2 2020 Aug 12, 2020	BUY	$15.49 - $23.51 $31,181 - $47,325	2,013 Added 1.08%	188,105 $3.29 Million
Q1 2020 May 06, 2020	SELL	$13.89 - $25.45 $101,021 - $185,097	-7,273 Reduced 3.76%	186,092 $3.04 Million
Q4 2019 Feb 14, 2020	SELL	$10.7 - $22.24 $2,097 - $4,359	-196 Reduced 0.1%	193,365 $3.98 Million
Q3 2019 Nov 07, 2019	BUY	$10.16 - $13.28 $40,822 - $53,359	4,018 Added 2.12%	193,561 $2.22 Million
Q2 2019 Aug 12, 2019	BUY	$10.62 - $16.59 $48,044 - $75,053	4,524 Added 2.45%	189,543 $2.49 Million
Q1 2019 May 14, 2019	SELL	$13.58 - $18.72 $35,688 - $49,196	-2,628 Reduced 1.4%	185,019 $2.8 Million
Q4 2018 Feb 11, 2019	SELL	$14.78 - $19.68 $140,720 - $187,373	-9,521 Reduced 4.83%	187,647 $3.22 Million
Q3 2018 Nov 09, 2018	SELL	$14.16 - $24.3 $578,535 - $992,825	-40,857 Reduced 17.17%	197,168 $0
Q2 2018 Aug 06, 2018	SELL	$21.79 - $28.29 $1.05 Million - $1.36 Million	-48,073 Reduced 16.8%	238,025 $5.68 Million
Q1 2018 May 15, 2018	BUY	$18.15 - $29.21 $1.12 Million - $1.8 Million	61,726 Added 27.51%	286,098 $7.31 Million
Q4 2017 Feb 09, 2018	BUY	$9.3 - $19.14 $2.09 Million - $4.29 Million	224,372	224,372 $4.14 Million

Others Institutions Holding COLL

# of Institutions

254

Shares Held

36.9M

Call Options Held

100K

Put Options Held

21.1K

Black Rock Inc. New York, NY

5.79M
Shares

$191 Million
0.0% of portfolio
Eventide Asset Management, LLC Boston, MA

2.64M
Shares

$86.7 Million
1.79% of portfolio
Pacer Advisors, Inc. Malvern, PA

2.59M
Shares

$85.2 Million
0.24% of portfolio
Vanguard Group Inc Valley Forge, PA

2.35M
Shares

$77.2 Million
0.0% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

1.66M
Shares

$54.5 Million
0.1% of portfolio

View Full List

About COLLEGIUM PHARMACEUTICAL, INC

Ticker COLL
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 34,126,200
Market Cap $1.12B
Description
Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...

More about COLL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of New York Mellon Corp with notifications on news.

Account